Opioid receptor selectivity alteration by single residue replacement: Synthesis and activity profile of [Dmt1]deltorphin B

European Journal of Pharmacology

Volumn 302, Issue 1-3, 1996, Pages 37-42

  Guerrini, Remo ^a   Capasso, Anna ^b   Sorrentino, Ludovico ^c   Anacardio, Roberto ^d   Bryant, Sharon D ^e   Lazarus, Lawrence H ^e   Attila, Martti ^f   Salvadori, Severo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d Chemistry Section   (Italy)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Antinociception; Bioassay; Deltorphin; Opioid receptor; Peptide synthesis

Indexed keywords

DELTA OPIATE RECEPTOR; DELTORPHIN; DELTORPHIN B; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTESTINE CONTRACTION; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; TAIL FLICK TEST;

EID: 0029975241     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00067-2     Document Type: Article

References (29)

1. Attila, M., S. Salvadori, G. Balboni, S.D. Bryant and L.H. Lazarus, 1993. Synthesis and receptor binding analysis of dermorphin hepta-, hexaand pentapeptide analogues. Evidence for one- and two-site binding models for the μ opioid receptor, Int. J. Pept. Prot. Res. 42, 550.
2. Baamonde, A., V. Douge, G. Gilles and B.P. Roques, 1991, Systemic administration of (Tyr-D-Ser(O-tert-butyl)-Gly-Phe-Leu-Thr(O-tert-butyl), a highly selective delta opioid agonist, induces mu receptormediated analgesia in mice, J. Pharmacol. Exp. Ther. 257, 767.
3. Breveglieri, A., R. Guerrini, S. Salvadori, C. Bianchi, S.D. Bryant, M. Attila and L.H. Lazarus, 1996, Design and synthesis of 1-amino-cycloalkane-1-carboxylic acid substituted deltorphin analogues: unique δ and μ opioid activity in modified peptides, J. Med. Chem. 39, 773.
4. Bryant, S.D., M. Attila, S. Salvadoi, R. Guerrini and L.H. Lazarus. 1994. Molecular dynamics conformations of deltorphin analogues advocate δ opioid binding site models, Peptide Res. 7, 175.
5. Bryant, S.D., S. Salvadori, G. Guerrini and L.H. Lazarus, 1996, Monte Carlo analysis of H-Dmt-Tic-OH verifies a new structural motif for ultraselective δ opioidmimetic dipeptide antagonists, J. Med. Chem. (in press).
6. Calderon, S.N., R.B. Rothman, F. Porreca, J.L. Flippen-Anderson, R.W. McNutt, H. Xu, L.E. Smith, E.J. Bilsky, P. Davis and K.C. Rice, 1994, Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(αR)-α((2S.5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide δ opioid receptor agonist, J. Med. Chem. 37, 2125.
7. Capasso, A., A. Di Giannuario, A. Loizzo, S. Pieretti and L. Sorrentino. 1992, Central interaction of dexamethasone and RU-38486 on morphine antinociception in mice, Life Science 51, PL 139.
8. Capasso, A., A. Di Giannuario, A. Loizzo, S. Pieretti and L. Sorrentino, 1993, Differential sensitivity to dexamethasone influence on morphine antinociception in two different strains of mice: DBA/2J and C57BL/6, Life Sci. 52, 835.
9. 50) of an enzymatic reaction, Biochem. Pharmacol. 22, 3099.
10. Erspamer, V., P. Melchiorri, G. Falconieri Erspamer, L. Negri, R. Corsi, C. Severini, D. Barra, M. Simmaco and G. Kreil, 1989, Deltorphins: a family of natural occurring peptides with high affinity and selectivity for δ opioid binding sites, Proc. Natl. Acad. Sci. USA 86, 5188.
11. Galligan, J.J., H.I. Mosberg, R. Hurst, V.J. Hruby and T.F. Burst, 1984, Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids, J. Pharmacol. Exp. Ther. 229, 641.
12. Haley, T.J. and W.G. McCormick, 1957. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse, Br. J. Pharmacol. Chemother. 12, 15.
13. Hammond, D.L., A. Stapelfeld, E.J. Drower, M.A. Savage, L. Tam and R.H. Mazur, 1994, Antinociception produced by oral, subcutaneous or intrathecal administration of SC-39566, an opioid dipeptide arylalkylamide, in the rodent, J. Pharmacol. Exp. Ther. 268, 607.
14. 5]enkephalin, J. Med. Chem. 35, 684.
15. Heyman, J.S., J.L. Vaught, R.B. Raffa and F. Porreca, 1988, Can supraspinal δ opioid receptors mediate antinociception?. Trends Pharmacol. Sci. 9, 134.
16. Hruby, V.J. and C.A. Gehring, 1989, Recent developments in the design of receptor specific opioid peptides, Med. Res. Rev. 9, 343.
17. 2-agonist antinociception, Neuroreport 5, 1049.
18. Lazarus, L.H., W.E. Wilson, R. De Castiglione and A. Guglietta, 1989, Dermorphin gene sequence peptide with high affinity for δ-opioid receptors, J. Biol. Chem. 264, 3047.
19. Lazarus, L.H., S.D. Bryant, M. Attila, S. Salvadori and L.S. Jones, 1996, Opioid infidelity. Novel opioid peptides with dual high affinities for δ and μ receptors, Trends Neurosci. 19, 31.
20. Martin, W.R., C.G. Eades, J.A. Thompson, R.A. Huffler and P.E. Gilbert, 1976, The effect of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther. 197, 517.
21. Persico, P., A. Capasso, A. Calignano and L. Sorrentino, 1991, The action of dexamethasone on electrically-induced contractions of guinea-pig isolated ileum, Gen. Pharmacol. 22, 319.
22. Porreca, F., H.I. Mosberg, R. Hurst, V.J. Hruby and T.F. Burks, 1984, Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse, J. Pharmacol. Exp. Ther. 230, 341.
23. Portoghese, P.S., M. Sultana, H. Nagase and A.E. Takemori, 1988, Application of the message-address concept in the design of highly potent and selective non-peptide δ-opioid receptor antagonists. J. Med. Chem. 31, 281.
24. Qian, X., K.E. Kover, M.D. Shenderovic, B.S. Lou, A. Misika, T. Zalewska, R. Horvath, P. Davis, E.J. Bilsky, F. Porreca, H.J. Yamamura and V.J. Hruby, 1994, Newly discovered stereochemical requirements in the side-chain conformation of δ opioid agonists for recognizing opioid δ receptors, J. Med. Chem. 37, 1746.
25. Robson, L.E., S.J. Paterson and H.W. Kosterlitz, 1983, Opiate receptors, Handbook Psychopharmacol. 17, 13.
26. Salvadori, S., M. Attila, G. Balboni, C. Bianchi, S.D. Bryant. O. Crescenzi, R. Guerrini, D. Picone, T. Tancredi, P.A. Temussi and L.H. Lazarus, 1995, δ Opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides, J. Mol. Med. 1, 678.
27. Tallarida, R.J. and R.B. Murray, 1987. Manual of Pharmacological Calculation with Computer Programs. 2nd edn. (Springer Verlag).
28. Temussi, P.A., S. Salvadori, P. Amodeo, C. Bianchi, R. Guerrini, R. Tomatis, L.H. Lazarus, D. Picone and T. Tancredi, 1994, Selective opioid dipeptides, Biochem. Biophys. Res. Commun. 198, 933.
29. Valeri, P., L.A. Morrone and L. Romanelli, 1992, Manifestation of acute opiate withdrawal contracture in rabbit jejunum after μ, κ and delta agonist exposure, Br. J. Pharmacol. 106, 39.